Stock Price Forecast

April 18, 2024


Forecasted Returns

7 Days Predict

30 Days Predict

90 Days Predict


Forecasted Market-Excess Returns

7 Days Predict

30 Days Predict

90 Days Predict

Loading HARROW, INC. chart...

About the Company

We do not have any company description for HARROW, INC. at the moment.

Sector

Life Sciences

Industry

Pharmaceutical Preparations

Employees

22

Exchange

Nasdaq

$7M

Total Revenue

22

Employees

$382M

Market Capitalization

-30.18

Price/Earning ratio

Fundamental Data and Insider Transactions (Quarterly data) Full Screen

Loading the fundamentals chart...

Latest $HROW News

Harrow Posts Weak Q4 Results, Joins TeraWulf, Nasdaq And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session

1mon ago, source: Business Insider

Shares of Harrow, Inc. (NASDAQ:HROW) fell sharply in today’s pre-market trading after posting weaker-than-expected fourth-quarter results. Harrow Health posted adjusted loss of 20 cents per ...

Melt Pharmaceuticals raises $24 million for drug development

17d ago, source: The Business Journals

The company is a former subsidiary of Harrow Inc. (Nasdaq: HROW), one of Middle Tennessee’s publicly traded health care ...

Harrow, Inc. (HROW) Q4 2023 Earnings Call Transcript

1mon ago, source: Seeking Alpha

Good morning and welcome to Harrow's Fourth Quarter and Year-End 2023 Earnings Conference Call. My name is Drew, and I will be your operator for today's call. At this time, all participants are in ...

Harrow Inc HROW

16d ago, source: Morningstar

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings ...

Harrow Stock (NASDAQ:HROW), Analyst Ratings, Price Targets, Predictions

8d ago, source: Benzinga.com

Harrow Inc has a consensus price target of $24.25, established from looking at the 7 latest analyst ratings. The last 3 analyst ratings were released from Craig-Hallum, B. Riley Securities ...

Harrow Health gets grant for preservative-free ophthalmic composition for dry eye disease

4d ago, source: Pharmaceutical Technology

Discover Harrow Health Inc's innovative patent for preservative-free ophthalmic compositions targeting ocular diseases like dry eye. Learn about the unique formulation stored in a convenient dropper ...

Harrow Health, Inc. (NASDAQ:HROW) Q4 2023 Earnings Call Transcript

1mon ago, source: Yahoo Finance

Harrow Health, Inc. (NASDAQ:HROW) Q4 2023 Earnings Call Transcript March 20, 2024 Harrow Health, Inc. isn't one of the 30 most popular stocks among hedge funds at the end of the third quarter (see ...

Q4 2023 Harrow Inc Earnings Call

1mon ago, source: Yahoo Finance

Jamie Webb; IR; Harrow, Inc. Mark L. Baum; CEO; Harrow, Inc. Andrew Boll; CFO; Harrow, Inc. Mayank Mamtani; Analyst; B. Riley Securities, Inc. Aaron Wukmir; Analyst ...

Harrow Health, Inc. (NASDAQ:HROW) Q4 2023 Earnings Call Transcript

29d ago, source: Insider Monkey

Harrow Health, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good morning and welcome to Harrow’s Fourth ...

Q4 2023 Harrow Inc Earnings Call

29d ago, source: Yahoo Finance

Q4 2023 Harrow Inc Earnings Call Q4 2023 Harrow Inc Earnings Call HOME MAIL NEWS FINANCE SPORT CELEBRITY STYLE WEATHER MORE... Yahoo Finance Sign in Mail Sign in to view your emails Finance News ...

Harrow Health, Inc. (NASDAQ:HROW) Q4 2023 Earnings Call Transcript

29d ago, source: Insider Monkey

Indeed, yesterday was special for every member of the Harrow family, and it was an answer to some of our prayers actually. In past letters to stockholders, as I mentioned earlier, I’ve opined ...

Latest Neutral (free) Forecasts

STRONG BUY BUY NEUTRAL SELL STRONG SELL ALL

Loading the latest forecasts...

My Portfolio

Loading your portfolio...